Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

US Patent 6740666 · Granted May 25, 2004

Estimated economic value: $166,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phe2024
Peptide macrocycles against Acinetobacter baumannii2024
Compositions and methods for treating disorders ameliorated by muscarinic recept2024
Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods fo2023
Compositions and methods for treating disorders ameliorated by muscarinic recept2022
Compositions and methods for treating disorders ameliorated by muscarinic recept2022
Peptide macrocycles against Acinetobacter baumannii2021
Libraries of heteroaryl-containing macrocyclic compounds and methods of making a2021
Compositions and methods for treating disorders ameliorated by muscarinic recept2021
Compositions and methods for treatment of disorders ameliorated by muscarinic re2021
Solid oral formulation of fenretinide2019
Solid oral formulation of fenretinide2019